Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT07408297
What this trial is testing

Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda

Who this might be right for
COVID -19SARS CoV 2 Infection
Victoria Biomedical Research Institute 1,919
Testing effectiveness (Phase 2)Study completedNCT00799058
What this trial is testing

A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States

Who this might be right for
HIV-1 Infections
International Partnership for Microbicides, Inc. 128
Large-scale testing (Phase 3)Study completedNCT00004583
What this trial is testing

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
Abbott 660
Large-scale testing (Phase 3)Study completedNCT02397096
What this trial is testing

Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 673
Not applicableLooking for participantsNCT06880224
What this trial is testing

Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation Hybrid Study

Who this might be right for
Adolescent HIV Infection
Northwestern University 500
Testing effectiveness (Phase 2)Study completedNCT01669096
What this trial is testing

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Who this might be right for
Tuberculosis
GlaxoSmithKline 20
Testing effectiveness (Phase 2)Study completedNCT00002442
What this trial is testing

Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Early research (Phase 1)Study completedNCT00002380
What this trial is testing

The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Who this might be right for
HIV Infections
Hoffmann-La Roche 28
Large-scale testing (Phase 3)UnknownNCT00009061
What this trial is testing

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 624
Not applicableLooking for participantsNCT04378439
What this trial is testing

Appalachian Partnership to Reduce Disparities (Aim 2)

Who this might be right for
HIV/AIDSSTIHCV
Wake Forest University Health Sciences 141
Large-scale testing (Phase 3)UnknownNCT01641016
What this trial is testing

BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection

Who this might be right for
HIV
PENTA Foundation 160
Testing effectiveness (Phase 2)Study completedNCT02572947
What this trial is testing

A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients

Who this might be right for
Human Immunodeficiency VirusDolutegravirMonotherapy+1 more
Calmy Alexandra 8
Early research (Phase 1)Study completedNCT00472719
What this trial is testing

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Testing effectiveness (Phase 2)Study completedNCT00040664
What this trial is testing

A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years

Who this might be right for
HIV Infection
ViiV Healthcare 69
Not applicableNot Yet RecruitingNCT06704204
What this trial is testing

Long-acting Injectable Antiretroviral Treatment to Improve HIV Treatment Among Justice-involved Persons Being Released to the Community

Who this might be right for
HIV
The Miriam Hospital 20
Early research (Phase 1)Study completedNCT00479999
What this trial is testing

Phase 1 Safety Study of Two Experimental HIV Vaccines

Who this might be right for
AIDS VaccinesHIV InfectionsHIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 35
Early research (Phase 1)Study completedNCT00001019
What this trial is testing

Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Ended earlyNCT02109224
What this trial is testing

Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaCutaneous B-Cell Non-Hodgkin Lymphoma+26 more
National Cancer Institute (NCI) 72
Large-scale testing (Phase 3)Study completedNCT00874523
What this trial is testing

Raltegravir and Atazanavir Dosing Strategy Study

Who this might be right for
HIV Infection
Kirby Institute 26
Not applicableStudy completedNCT00705419
What this trial is testing

Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 180
Next Page